ly3437943 retatrutide A Study of (LY3437943) in Participants With Obesity and Cardiovascular Disease (TRIUMPH-3) Retatrutide (LY3437943) — Third-Party Tested

Long-Term Care Hormonal Changes: If your ovaries were removed along with your uterus, you may experience menopausal symptoms such as hot flashes, mood swings, or sleep disturbances

11 Our findings indicate that, when used as a standalone treatment, ALC significantly reduced depressive symptoms compared to placebo or no treatment

Male C57Bl/6 mice (Charles River, UK) were fed a 60% high fat diet (D12492, Research Diets, USA) for 3 months prior to the study to induce obesity and glucose intolerance

ProulxJJoshiCVijayaraghavaluSSaraswathyMLabhasetwarVGhorpadeAet alArginine-modified polymers facilitate poly (lactide-co-glycolide)-based nanoparticle gene delivery to primary human astrocytes